NCT05571046

Glucocorticoid Injection in Patients With Lumbar Radicular Pain

Efficacy of Intramuscular Glucocorticoid Injection in Patients With Lumbar Radicular Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Cukurova University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to demonstrate the efficacy of intramuscular betamethasone injection on pain and other clinical parameters in patients with radicular pain due to lumbar disc herniation. The investigators also aimed to determine the effects on electrophysiological findings.

Detailed description

Low back pain is an important health problem that causes difficulties in daily living activities, loss of work performance and disability. Some patients with low back pain have radicular symptoms due to intervertebral disc herniation. Lumbar radiculopathy is characterized by radiating buttock and leg pain in a lumbar nerve root distribution. The pathophysiology of radiculopathy is related to compression of the nerve, as well as the local release of inflammatory cytokines. Systemic corticosteroids have been used for treatment of lumbar radicular pain for a long time. The effects of corticosteroids are related to their anti-inflammatory effects, which may help reduce swelling and related compression on the affected nerve. Corticosteroids can be used systemically (i.e. oral, intravenous, or intramuscular routes) or administered directly into spinal structures through injections. In the current study, the investigators aimed to demonstrate the efficacy of intramuscular betamethasone injection on pain, disability and health related quality of life in patients with lumbar radicular pain due to disc herniation. The investigators also aimed to determine the effects on electrophysiological findings.

Conditions

• Radiculopathy Lumbar

Interventions

Type	Name	Description
DRUG	Glucocorticoids	Intramuscular injection of single dose of 1 ml betamethasone, Paracetamol (500 mg, 2 times a day)
OTHER	Placebo	Intramuscular injection of %0.9 isotonic sodium chloride, Paracetamol (500 mg, 2 times a day)

Timeline

• Start date: 2022-06-01
• Primary completion: 2023-10-12
• Completion: 2023-10-26
• First posted: 2022-10-07
• Last updated: 2023-11-01

Locations

1 site across 1 country: Turkey (Türkiye)